On May 2, 2023, in a move intended to accelerate the adoption of digital health technologies, the U.S. Food and Drug Administration (“FDA”) released draft guidance regarding the conduct of decentralized clinical trials (“DCTs”) for drugs, biological products and devices. This draft guidance expands on previous FDA recommendations released in the midst of the... READ MORE
Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials
Posted on September 14, 2023 in Health Law News
Published by: Hall Render
